One‐step on‐column purification and refolding of a single‐chain variable fragment (scFv) antibody against tumour necrosis factor α
Authors:
- 1 March 2006
- journal article
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 43 (3) , 137-145
Abstract
Single‐chain variable fragment (scFv) is a low‐molecular‐mass recombinant antibody and is usually expressed as inclusion bodies in Escherichia coli. Highly efficient purification and refolding methods are required to provide enough active proteins for therapeutic or diagnostic use. In the present study, an anti‐TNFα (tumour necrosis factor α) scFv (TNF‐scFv) was constructed and expressed in E. coli BL21(DE3) star as inclusion bodies, and a convenient procedure of one‐step on‐column purification and refolding was provided for it. Briefly, denatured TNF‐scFv was firstly captured by immobilized metal (Ni) affinity chromatography, and then non‐denaturing detergent (Triton X‐100)‐containing and β‐cyclodextrin‐containing solutions were loaded in turn on to the column to perform ‘artificial chaperone‐assisted refolding’ after removing impurities. More than 77% of denatured TNF‐scFv protein was refolded successfully with a purity of more than 95%. Activity assays showed that refolded TNF‐scFv could bind to rhTNFα (recombinant human TNFα) specifically with high affinity. It could inhibit rhTNFα from binding to TNF receptors and neutralize the cytolytic activity of rhTNFα against L929 cells effectively. A conclusion was obtained that this refolding method is time‐saving and suitable for industrial production. It may also be applicable to other scFvs or other recombinant proteins.Keywords
This publication has 37 references indexed in Scilit:
- Gene cloning, bacterial expression, in vitro refolding, and characterization of a single-chain Fv antibody against PreS1(21–47) fragment of HBsAgProtein Expression and Purification, 2005
- Purification and refolding of a novel cancer/testis antigen BJ-HCC-2 expressed in the inclusion bodies of Escherichia coliProtein Expression and Purification, 2003
- Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trialArthritis & Rheumatism, 2003
- Chromatographic Methods for the Isolation of, and Refolding of Proteins from, Escherichia coli Inclusion BodiesProtein Expression and Purification, 2002
- Bacterial Expression and in Vitro Refolding of a Single-Chain Fv Antibody Specific for Human Plasma Apolipoprotein B-100Protein Expression and Purification, 2002
- Refolding and Characterization of a Yeast Dehydrodolichyl Diphosphate Synthase Overexpressed in Escherichia coliProtein Expression and Purification, 2001
- Protein refolding at high concentration using size-exclusion chromatographyBiotechnology and Bioengineering, 1996
- Identification and characterization of a TNFα antagonist derived from a monoclonal antibodyMolecular Immunology, 1994
- Monoclonal anti-tumor necrosis factor (TNF) antibodies protect mouse and human cells from TNF cytotoxicityJournal of Immunological Methods, 1991
- The prospects for therapy with tumour necrosis factors and their antagonistsTrends in Biotechnology, 1991